Sarcomas are connective tissue tumors accounting for only 1% of all adult malignancies. Leiomyosarcoma (LMS) is a sarcoma arising from smooth muscle cells, and accounts for 10-20% of all sarcomas. A subtype of LMS are those originating from the smooth muscle of blood vessels. Leiomyosarcoma of the inferior vena cava is a sarcomatous tumor, with less than 350 cases described in the literature. It carries a poor prognosis, with 5-and 10-year survival rates of 31.4% and 7.4%, respectively. We present a case of a 46-year-old female with no significant past medical history presented to the emergency department with mild abdominal pain and distention, early satiety, and weight loss for three weeks, found to have unresectable metastatic leiomyosarcoma of the inferior vena cava.
CASE REPORT
A 46-year-old female with no significant past medical history presented with a 3-week history of non-radiating, dull but progressively worsening right upper quadrant abdominal pain, as well as early satiety, nausea, vomiting, productive cough, and 15% unintentional weight loss. Contrast enhanced computed tomography (CT) was performed to assess for a cause of the patient's symptoms. CT scan revealed a 15.4 cm heterogeneously enhancing mass, arising from the right retroperitoneum, although without clear origin of the mass. There was involvement the sub-hepatic inferior vena cava as well as mass effect and anterior displacement of upon adjacent solid organs (Figure 1 ). Additional imaging findings included several hypoenhancing liver lesions and multiple solid pulmonary nodules, consistent with hepatic and pulmonary metastases (Figure 2 ).
Due to the uncertain origin of the mass and nonspecific imaging findings, a CT guided biopsy was performed for pathological diagnosis. Histologic analysis revealed malignant proliferation of spindle cells with frequent pleomorphic nuclei, frequent mitoses, and areas of necrosis ( Figure 3 ). Immunohistochemical stains were diffusely positive for vimentin, calponin, and caldesmon, weakly positive for actin, and partially positive for desmin expression (Figure 4 ). The constellation of histologic features, combined with imaging findings of a retroperitoneal mass involving the IVC, a diagnosis of primary leiomyosarcoma of the inferior vena cava (IVC) was rendered.
Due to the presence of metastatic disease at initial diagnosis, surgical resection was deferred, and the patient was referred to medical oncology for chemotherapy. Several chemotherapy regimens were employed, with several lines of treatment. Chemotherapy included four cycles of MAI (ifosfamide, doxorubicin, and mesna), three cycles of docetaxel, gemcitabine, and olaratumab, oral pazobanib, and six cycles of trabectedin. Despite several lines and cycles of chemotherapy, there was continued disease progression ( Figures 5-6 ). Ultimately, hospice care was recommended with palliative dacarbazine. The patient survived for 29 months after initial diagnosis.
Etiology & Demographics:
Sarcomas are connective tissue tumors accounting for only 1% of all adult malignancies [1] . Leiomyosarcoma (LMS) is a sarcomatous tumor accounts for 10-20% of all sarcomas, which arises from smooth muscle cell lineage and can affect various organs, such as the skin, gastrointestinal tract, uterus, and blood vessels [2] [3] [4] . Vascular leiomyosarcomas are LMS arising from blood vessel walls and represent 1-2% of all LMS, rarely affecting the IVC [5] . In fact, LMS of the IVC accounts for only 5% of all vascular LMS with less than 350 cases described in the literature [1-4]. These vascular LMS tumors are generally chemotherapy resistant and carry a poor prognosis. LMS of the IVC has a higher female incidence (3:1) and an average age of 54 years at the time of diagnosis [4] [5] [6] [7] .
When originating in veins, including the IVC, LMS typically forms in the tunica media and can have different growth patterns: extraluminal, intraluminal, or combined [7] . For surgical planning, LMS of the IVC is usually classified based on the location of the primary tumor into three segments, describing the location and extension of the tumor [8] . Segment I am classified as an infrarenal extension; segment II spares the suprahepatic veins but includes the interand suprarenal veins; and segment III includes the suprahepatic veins with possible cardiac extension, which carries the worst prognosis [7, 8] .
Clinical & Imaging Findings:
The most common presenting symptom reported in the literature is nonspecific abdominal pain among a variety of other symptoms and clinical presentations, such as BuddChiari syndrome, lower extremity edema, hepatomegaly, ascites, and jaundice secondary to hepatic metastases [1, 2]. In the later stages of the disease, metastases occur in less than 50% of patients with LMS of the IVC, commonly in the liver, lung, lymph nodes, or bone [1] . Pathologic examination showing fascicles of spindle cells with hyperchromatic nuclei and characteristic immunohistochemical stain pattern is necessary for appropriate diagnosis, with the use of imaging aiding in management [3, 9] . Establishment of LMS of the IVC as the site of origin requires an evaluation of the size, the pattern of growth, and the extent of luminal narrowing of the IVC on cross sectional images, e.g., CT or MRI. On CT, LMS of the IVC usually appears as heterogeneously enhancing mass with central necrosis in the retroperitoneum involving the perihepatic IVC, sometimes with mass effect on surrounding organs. CT is also helpful to show internal calcification secondary to necrosis, although this is an uncommon feature.
MRI of LMS usually demonstrates a soft tissue mass involving the IVC, which is homogeneously hypointense on T1, intermediate T2 signal intensity, and progressive avid enhancement on post-contrast T1 sequence. MRI is particularly helpful is assessing intraluminal tumors, which may be difficult to delineate on CT, especially on unenhanced CT. MRI sequences can differentiate T2 hypointense patent blood vessels from the higher signal intensity solid tumor. Because these tumors enhance, both CT and MR are useful in delineating tumor from bland thrombus. On ultrasound (US), LMS of the IVC appears as heterogeneous hypoechoic retroperitoneal mass with internal color flow [10] . Imaging also guides surgical and medical management, as it allows for tumor characterization, tumor localization, and evaluating for metastases. 
Treatment

Differential Diagnosis:
LMS of the IVC is a rare tumor that can mimic or be mistaken for many other retroperitoneal pathologies [13, 14] . Examples of solid organ tumors that can mimic LMS of the IVC are renal nephroblastoma (Wilms tumor), which originates from the kidney, or adrenal neuroblastoma, which tends to displace the kidney inferiorly, cross midline, and displace the abdominal aorta anteriorly. Both entities are commonly seen in pediatric patients as heterogeneously enhancing retroperitoneal mass on CT and MRI [15] . In adults, hilar cholangiocarcinoma is a peritoneal malignancy of the liver that can extend into the retroperitoneum and mimic LMS of the IVC, which appears on CT as a hypoenhancing liver mass, with associated intrahepatic ductal dilatation [16] . The duodenum is a retroperitoneal visceral organ with proximity to the IVC, which can be affected by a variety of benign and malignant processes; e.g., epithelial, mesenchymal, smooth muscle, lymphoproliferative, and neuroendocrine tumors. The predominant presenting symptoms of duodenal malignancy are abdominal pain, weight loss, bowel obstruction, nausea and vomiting [17] . Adrenal pheochromocytoma is also a retroperitoneal solid organ tumor presents as liable blood pressure and headache, and can be seen on CT or MRI images as avidly enhancing solid and cystic mass (low density on CT and T2 hyperintense signal on MRI) with central hemorrhage, necrosis, and calcification [18] .
Non-solid organ tumors of the retroperitoneum may be benign or malignant, and are classified by their respective cell lineage, including: mesodermal, neurogenic, germinal, or lymphoid origins [14] . Lipomatosis and Erdheim-Chester disease (a non-Langerhans form of histiocytosis) are examples of mesodermal retroperitoneal non-solid organ tumors. Lipomatosis may lead to asymptomatic abdominal distention. On CT, lipomatosis shows fatty proliferation with fibrous strands appearance on CT surrounding anatomic structures in the pelvis. On MRI, retroperitoneal lipomatosis demonstrates signal loss on fat suppression sequences. Cystic teratoma is an asymptomatic germ cell tumor, which appears on CT as a complex cystic mass, consisting of fat and calcification on CT, US, and MRI [19] . Lymphangiomatosis, or invasive lymphangioma, is an asymptomatic retroperitoneal nonenhancing cystic mass with thick septation and minimal calcifications that can extend along tissue planes on CT with T2 hyperintense signal on MRI [20] . On the other hand, extrapulmonary lymphangioleiomyomatosis (LAM), commonly seen in patients with history of tuberous sclerosis, is a lymphatic obstruction caused by the proliferation of smooth muscle cells that can affect lungs, kidneys, and retroperitoneal lymph nodes leading to a formation of a retroperitoneal homogenously hypoattenuating cystic mass encasing the IVC without invasion on CT, and T2 hyperintense signal on MRI with normal flow void of the IVC [21] . Extramedullary hematopoiesis is hematopoietic tissue outside of bone marrow appears on CT imaging as a paravertebral hyperattenuating or isoattenuating round or lobulated mass, which can be confirmed with liver-spleen sulfur colloid nuclear medicine scan [22] .
Several malignant non-solid organ tumors of the retroperitoneum are also included in the differential diagnosis. Liposarcoma, myxoid liposarcoma, and lipomyosarcoma are the most common types of retroperitoneal soft tissue sarcomas that are usually asymptomatic and appears as lipid rich lesions similar to lipomatosis but with mural enhancement on CT and MRI [23] [24] [25] [26] [27] . Malignant fibrous histiocytoma is the third most common retroperitoneal sarcomas, usually asymptomatic and appears on CT and MRI as an infiltrating, avidly enhancing soft-tissue mass with areas of necrosis and hemorrhage, and invasion of adjacent organs [28, 29] . Other uncommon sarcomas of the retroperitoneum are rhabdomyosarcoma, which is a pediatric mesenchymal tumor with intense enhancement on CT and MRI; extra skeletal chondrosarcoma of the retroperitoneum, which is a rare tumor usually seen on CT and MRI as a heterogeneously dense mass with arc type of calcifications; and synovial cell sarcoma-a rare tumor presents as hypodense soft tissue mass on CT, T2 hyperintense on MRI, and tends to occur near major joints [30] [31] [32] .
Malignant vascular tumors of the retroperitoneum, besides LMS of the IVC, are angiosarcoma and perivascular epithelioid cell tumor, also known as PEComa. Angiosarcoma involves the endothelial layer of vessels causing expansion and hypodense, hypoenhancing filling defect on CT that can mimic a bland thrombus [33] [34] [35] . The major MRI features of angiosarcoma are T1 isointense to hyperintense signal and T2 hyperintense signal with minimal enhancement. The presence of high-flow serpentine vessels (T2 flow void signal on MRI) in a vascular-based soft tissue mass is highly specific for angiosarcoma [35] . PEComa, such as clear cell and myomelanocytic tumors, pigmented melanotic tumors, and sarcoma of perivascular cells are perivascular tumors that can develop around a vascular lumen with variable heterogeneously enhancing CT and MRI appearance [36] [37] [38] .
Neurogenic tumors are asymptomatic tumors that can mimic masses of the retroperitoneum [39] . Schwannoma appears as solid well-circumscribed low density minimally enhancing mass on CT and MRI [40, 41] . Neurofibroma and plexiform neurofibroma are hypoenhancing retroperitoneal masses encasing the surrounding vessels on CT, which are commonly seen in type 1 neurofibromatosis [42, 43] . Malignant nerve sheath tumors, ganglioneuroma, and paraganglioma are usually symptomatic tumors present as dull flank or abdominal pain. On CT, they appear as well-margined hypodense, hypoenhacning retroperitoneal masses with internal feeding vessels [44] [45] [46] .
Isolated or mixed germ cell-sex cord-stromal tumors of the retroperitoneum such as seminoma, malignant teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and mixed germ cell tumor are frequently asymptomatic tumors with nonspecific imaging findings on CT, usually appear as solid hypoattenuating, heterogeneously enhancing masses with cystic changes and retroperitoneal lymphadenopathy on contrast enhanced CT or MRI [47] [48] [49] .
Retroperitoneal fibrosis and retroperitoneal lymphoma can share similar features with LMS of the IVC. Retroperitoneal fibrosis is collagen vascular disease that is generally idiopathic, thought to be autoimmune-mediated, and can appear as a para-aortocaval hypoattenuating homogenously hypoenhancing soft tissue mass, encasing the surrounding vasculature, with associated minimal aortic displacement, medial deviation of the ureters, vascular thrombus, and obstructive uropathy [50] [51] [52] . The most common presenting symptoms for retroperitoneal fibrosis are back pain, abdominal pain, fatigue, fever, high erythrocyte sedimentation rate, and proteinuria, and the treatment is usually steroids, diseasemodifying antirheumatic drugs, tamoxifen, or surgery [53, 54] . Retroperitoneal lymphoma can present as abdominal pain, fatigue, abdominal swelling, fever, high erythrocyte sedimentation rate, or anemia, and CT features of retroperitoneal lymphoma are enhancing soft tissue with relatively smooth margins, marked anterior displacement of the aorta, lymphadenopathy, and splenomegaly [55] . Zhang et al. reported that the most specific CT finding for retroperitoneal fibrosis is medial deviation of the ureters, while the most specific imaging finding for retroperitoneal lymphoma is the presence of lymphadenopathy, followed by splenomegaly, and anterior aortic displacement [50] .
Leiomyosarcoma of the inferior vena cava is a rare subtype of soft tissue sarcoma, with only a few hundred cases described in the literature.
These tumors carry a poor prognosis, particularly when surgical resection is not possible. Leiomyosarcoma of the IVC is typically resistant to chemotherapy and radiation with palliative chemotherapy employed solely to prolong survival. 
Extramedullary Hematopoiesis
History of anemia or sickle cell disease.
Paravertebral iso-or hyperenhancing round or lobulated mass.
Intense uptake on liver-spleen sulfur colloid nuclear medicine scan.
Retroperitoneal Liposarcoma
Usually asymptomatic.
Heterogeneously hypodense due to fat content. Dedifferentiated tumors may have calcification (in up to 30% of cases).
T1 high signal, T2 intermediate signal, and loss of signal on fat suppression sequences on MRI.
Retroperitoneal
Malignant Fibrous Histiocytoma
Usually asymptomatic. Infiltrating, heterogeneously enhancing soft-tissue mass with areas of necrosis, hemorrhage, and invasion of adjacent organs.
T1 hyperintense if hemorrhagic, T2 hypointense signal, and avid enhancement on MRI. 
Angiosarcoma of the IVC
Retroperitoneal Neurogenic Tumors
Dull flank or abdominal pain.
Hypoenhancing or hyperenhancing paravertebral soft tissue lesions.
T1 hyperintense, T2 hypointense, with avid enhancement on MRI.
Retroperitoneal Germ Cell Tumors
Usually asymptomatic. Heterogeneously hypoenhancing masses with cystic changes.
Variable T1 and T2 signal with heterogeneous enhancement on MRI.
Retroperitoneal Lymphoma
Abdominal pain, fatigue, fever, high erythrocyte sedimentation rate, and anemia.
Poorly defined homogeneous infiltrating mass, with mild enhancement, encasing vasculature.
T1 isointense and T2 hypointense infiltrating mass with avid enhancement and restricted diffusion on MRI.
Retroperitoneal Fibrosis
Back pain, abdominal pain, fatigue, fever, high erythrocyte sedimentation rate, and proteinuria.
Mildly enhancing soft tissue mass encasing the aorta, and sometimes ureters, and cause ureteral obstruction and venous thrombosis of the IVC.
T1 isointense and T2 hypointense mass encasing vasculature and retroperitoneal structures on MRI. 
Treatment
Surgical treatment is preferred if localized to the wall of the IVC. Chemotherapy is the mainstay of treatment for cases with metastatic disease.
Prognosis
The 5-year and 10-year survival rates after surgical resection have been reported to be 31.4% and 7.4%, respectively, with 0% survival observed with incomplete resection or inoperable cases, with or without the chemoradiation therapy.
Findings on Imaging
On CT, LMS of the IVC usually appears as heterogeneously enhancing mass with central necrosis and calcification in the retroperitoneum involving the perihepatic IVC, sometimes with mass effect on surrounding organs. On MRI, LMS of the IVC usually demonstrates a soft tissue mass involving the IVC, which is homogeneously hypointense on T1, intermediate T2 signal intensity, and progressive avid enhancement on post-contrast T1 sequence. On US, LMS of the IVC appears as heterogeneous hypoechoic retroperitoneal mass with internal color flow. 
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